BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21789140)

  • 1. Chemotherapy in newly diagnosed primary central nervous system lymphoma.
    Hashemi-Sadraei N; Peereboom DM
    Ther Adv Med Oncol; 2010 Jul; 2(4):273-92. PubMed ID: 21789140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system lymphoma.
    Ahluwalia MS; Peereboom DM
    Curr Treat Options Neurol; 2010 Jul; 12(4):347-59. PubMed ID: 20842593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the therapy of primary central nervous system lymphoma.
    Plotkin SR; Batchelor TT
    Clin Lymphoma; 2001 Mar; 1(4):263-75; discussion 276-7. PubMed ID: 11707839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and treatment of primary central nervous system lymphoma.
    Algazi AP; Kadoch C; Rubenstein JL
    Neurotherapeutics; 2009 Jul; 6(3):587-97. PubMed ID: 19560747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphoma.
    Löw S; Han CH; Batchelor TT
    Ther Adv Neurol Disord; 2018; 11():1756286418793562. PubMed ID: 30305848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
    Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Central Nervous System Lymphoma (PCNSL): Analysis of Treatment by Gamma Knife Radiosurgery and Chemotherapy in a Prospective, Observational Study.
    Alvarez-Pinzon AM; Wolf AL; Swedberg H; Coy SR; Valerio JE
    Cureus; 2016 Jul; 8(7):e697. PubMed ID: 27570717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of additional radiotherapy for primary central nervous system lymphoma.
    Zacher J; Kasenda B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009211. PubMed ID: 24931518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
    Chamberlain MC; Kormanik P; Glantz M
    Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and challenges in the treatment of primary central nervous system lymphoma.
    Yang H; Xun Y; Yang A; Liu F; You H
    J Cell Physiol; 2020 Dec; 235(12):9143-9165. PubMed ID: 32420657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
    Wirdah A; Djamaludin N; Syahrir M; Andayani YD; Andriani M; Diansari Y
    Acta Med Indones; 2023 Jan; 55(1):107-109. PubMed ID: 36999259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the blood-brain barrier in primary central nervous system lymphoma.
    Jahnke K; Doolittle ND; Muldoon LL; Neuwelt EA
    Neurosurg Focus; 2006 Nov; 21(5):E11. PubMed ID: 17134113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
    Isbell LK; Uibeleisen R; Friedl A; Burger E; Dopatka T; Scherer F; Orban A; Lauer E; Malenica N; Semenova I; Vreden A; Valk E; Wendler J; Neumaier S; Fricker H; El Rabih AAH; Gloggengießer C; Hilbig D; Bleul S; Weis J; Gmehlin D; Backenstrass M; Wirtz S; Ihorst G; Finke J; Illerhaus G; Schorb E
    BMC Cancer; 2023 Aug; 23(1):767. PubMed ID: 37596517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Central Nervous System Lymphoma.
    Han CH; Batchelor TT
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1601-1618. PubMed ID: 29200113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of newly diagnosed primary central nervous system lymphomas.
    Qian L; Tomuleasa C; Florian IA; Shen J; Florian IS; Zdrenghea M; Dima D
    Blood Res; 2017 Sep; 52(3):159-166. PubMed ID: 29043230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances and challenges in primary central nervous system lymphoma: a narrative review.
    Ma L; Gong Q
    Transl Cancer Res; 2023 May; 12(5):1335-1352. PubMed ID: 37304530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.